Literature DB >> 20088608

Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum.

Simeon Andrews1, Steven J Burgess, Deborah Skaalrud, Jane Xu Kelly, David H Peyton.   

Abstract

We have shown that "reversed chloroquine molecules" constructed from chloroquine-like and resistance "reversal-agent"-like cores can be powerful drugs against malaria ( J. Med. Chem. 2006 , 49 , 5623 - 5625 ). Several reversed chloroquines are now presented that probe parameters governing the activities against chloroquine-resistant and chloroquine-sensitive malaria strains. The design is tolerant to linker and reversal agent changes, but a piperazinyl group adjacent to the quinoline, at least for the group of compounds studied here, may be detrimental.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088608      PMCID: PMC2929814          DOI: 10.1021/jm900972u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.

Authors:  Steven J Burgess; Audrey Selzer; Jane Xu Kelly; Martin J Smilkstein; Michael K Riscoe; David H Peyton
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

2.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas.

Authors:  Kekeli Ekoue-Kovi; Kimberly Yearick; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

3.  Reversed chloroquines based on the 3,4-dihydropyrimidin-2(1H)-one scaffold: synthesis and evaluation for antimalarial, beta-haematin inhibition, and cytotoxic activity.

Authors:  Natasha October; Nicholas D Watermeyer; Vanessa Yardley; Timothy J Egan; Kanyile Ncokazi; Kelly Chibale
Journal:  ChemMedChem       Date:  2008-11       Impact factor: 3.466

4.  Arylpiperazines displaying preferential potency against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum.

Authors:  Carrie-Anne Molyneaux; Miriam Krugliak; Hagai Ginsburg; Kelly Chibale
Journal:  Biochem Pharmacol       Date:  2005-11-18       Impact factor: 5.858

Review 5.  Should chloroquine be laid to rest?

Authors:  Hagai Ginsburg
Journal:  Acta Trop       Date:  2005-10       Impact factor: 3.112

Review 6.  Malaria.

Authors:  Brian M Greenwood; Kalifa Bojang; Christopher J M Whitty; Geoffrey A T Targett
Journal:  Lancet       Date:  2005 Apr 23-29       Impact factor: 79.321

7.  Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers.

Authors:  D A van Schalkwyk; J C Walden; P J Smith
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines.

Authors:  Kimberly Yearick; Kekeli Ekoue-Kovi; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  J Med Chem       Date:  2008-03-18       Impact factor: 7.446

9.  Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.

Authors:  David C Warhurst; John C Craig; Ipemida S Adagu; R Kiplin Guy; Peter B Madrid; Quinton L Fivelman
Journal:  Biochem Pharmacol       Date:  2007-03-19       Impact factor: 5.858

Review 10.  Current issues for anti-malarial drugs to control P. falciparum malaria.

Authors:  D Schellenberg; S Abdulla; C Roper
Journal:  Curr Mol Med       Date:  2006-03       Impact factor: 2.222

View more
  15 in total

1.  A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

Authors:  Igor Opsenica; James C Burnett; Rick Gussio; Dejan Opsenica; Nina Todorović; Charlotte A Lanteri; Richard J Sciotti; Montip Gettayacamin; Nicoletta Basilico; Donatella Taramelli; Jonathan E Nuss; Laura Wanner; Rekha G Panchal; Bogdan A Solaja; Sina Bavari
Journal:  J Med Chem       Date:  2011-01-25       Impact factor: 7.446

2.  3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.

Authors:  Sonia Edaye; Dagobert Tazoo; D Scott Bohle; Elias Georges
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

3.  Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds.

Authors:  Steven J Burgess; Jane X Kelly; Shawheen Shomloo; Sergio Wittlin; Reto Brun; Katherine Liebmann; David H Peyton
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

4.  The Ca2+-ATPase (SERCA1) is inhibited by 4-aminoquinoline derivatives through interference with catalytic activation by Ca2+, whereas the ATPase E2 state remains functional.

Authors:  Gianluca Bartolommei; Francesco Tadini-Buoninsegni; Maria Rosa Moncelli; Sandra Gemma; Caterina Camodeca; Stefania Butini; Giuseppe Campiani; David Lewis; Giuseppe Inesi
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

5.  Zinc-Chelating Small Molecules Preferentially Accumulate and Function within Pancreatic β Cells.

Authors:  Timothy M Horton; Paul A Allegretti; Sooyeon Lee; Hannah P Moeller; Mark Smith; Justin P Annes
Journal:  Cell Chem Biol       Date:  2018-12-06       Impact factor: 8.116

6.  Synthesis and Antimalarial Activity of 4-Methylaminoquinoline Compounds against Drug-Resistant Parasite.

Authors:  Vinay Shankar Tiwari; Prince Joshi; Kanchan Yadav; Anamika Sharma; Sushobhan Chowdhury; Ashan Manhas; Niti Kumar; Renu Tripathi; Wahajul Haq
Journal:  ACS Omega       Date:  2021-05-11

Review 7.  Reversed chloroquine molecules as a strategy to overcome resistance in malaria.

Authors:  David H Peyton
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

8.  Expanding the Antimalarial Drug Arsenal-Now, But How?

Authors:  Brian T Grimberg; Rajeev K Mehlotra
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-01

9.  Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.

Authors:  Anna Caroline Campos Aguiar; Raquel de Meneses Santos; Flávio Júnior Barbosa Figueiredo; Wilian Augusto Cortopassi; André Silva Pimentel; Tanos Celmar Costa França; Mario Roberto Meneghetti; Antoniana Ursine Krettli
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

10.  Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria.

Authors:  Seon-Ju Yeo; Dong-Xu Liu; Hak Sung Kim; Hyun Park
Journal:  Malar J       Date:  2017-02-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.